Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan M Weiss

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
JAMA Dermatology|January 15, 2016
Necrobiotic Xanthogranuloma Treated With Topical Nitrogen Mustard (Mechlorethamine)Olaf Rodriguez, Charles Meyers, Brendan M Weiss, et al.
American Journal of Hematology|March 9, 2016
Reappraisal of risk factors for monoclonal gammopathy of undetermined significanceBen Boursi, Brendan M Weiss, Kevin Haynes, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 3, 2007
Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysisAndrew F Shorr, William L Jackson, Brendan M Weiss, et al.
Medicine|February 7, 2020
AA amyloidosis associated with Castleman disease: A case report and review of the literatureLuca Bernabei, Adam Waxman, Gabriel Caponetti, et al.
Blood|February 24, 2009
A monoclonal gammopathy precedes multiple myeloma in most patientsBrendan M Weiss, Jude Abadie, Pramvir Verma, et al.
Leukemia & Lymphoma|June 9, 2011
Current and future imaging modalities for multiple myeloma and its precursor statesEsther Tan, Brendan M Weiss, Esther Mena, et al.
Journal of Thrombosis and Thrombolysis|November 6, 2007
Optical density values correlate with the clinical probability of heparin induced thrombocytopeniaBrendan M Weiss, Nathan M Shumway, Robin S Howard, et al.
American Journal of Hematology|May 6, 2011
Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patientsBrendan M Weiss, Alex Minter, Jude Abadie, et al.
Critical Care Medicine|July 18, 2008
Massive transfusion and nonsurgical hemostatic agentsJeremy G Perkins, Andrew P Cap, Brendan M Weiss, et al.
The Journal of Clinical Investigation|November 2, 2016
mTOR has distinct functions in generating versus sustaining humoral immunityDerek D Jones, Brian T Gaudette, Joel R Wilmore, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
JAMA Dermatology|January 15, 2016
Necrobiotic Xanthogranuloma Treated With Topical Nitrogen Mustard (Mechlorethamine)Olaf Rodriguez, Charles Meyers, Brendan M Weiss, et al.
American Journal of Hematology|March 9, 2016
Reappraisal of risk factors for monoclonal gammopathy of undetermined significanceBen Boursi, Brendan M Weiss, Kevin Haynes, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 3, 2007
Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysisAndrew F Shorr, William L Jackson, Brendan M Weiss, et al.
Medicine|February 7, 2020
AA amyloidosis associated with Castleman disease: A case report and review of the literatureLuca Bernabei, Adam Waxman, Gabriel Caponetti, et al.
Blood|February 24, 2009
A monoclonal gammopathy precedes multiple myeloma in most patientsBrendan M Weiss, Jude Abadie, Pramvir Verma, et al.
Leukemia & Lymphoma|June 9, 2011
Current and future imaging modalities for multiple myeloma and its precursor statesEsther Tan, Brendan M Weiss, Esther Mena, et al.
Journal of Thrombosis and Thrombolysis|November 6, 2007
Optical density values correlate with the clinical probability of heparin induced thrombocytopeniaBrendan M Weiss, Nathan M Shumway, Robin S Howard, et al.
American Journal of Hematology|May 6, 2011
Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patientsBrendan M Weiss, Alex Minter, Jude Abadie, et al.
Critical Care Medicine|July 18, 2008
Massive transfusion and nonsurgical hemostatic agentsJeremy G Perkins, Andrew P Cap, Brendan M Weiss, et al.
The Journal of Clinical Investigation|November 2, 2016
mTOR has distinct functions in generating versus sustaining humoral immunityDerek D Jones, Brian T Gaudette, Joel R Wilmore, et al.
Pageof 6